Skip to main content
COOPER COMPANIES, INC. logo

COOPER COMPANIES, INC. — Investor Relations & Filings

Ticker · COO ISIN · US2166485019 LEI · QJKMVPIGLH7530PCUE20 US Manufacturing
Open in API
Filings indexed 1,279 across all filing types
Latest filing 2024-07-08 Management Reports
Country US United States of America
Listing US COO

About COOPER COMPANIES, INC.

https://www.coopercos.com/

Cooper Companies, Inc. is a global medical device company that operates through two primary business units: CooperVision and CooperSurgical. CooperVision is a leading developer and manufacturer of soft contact lenses and related products, offering a comprehensive portfolio for a wide range of vision correction needs. CooperSurgical focuses on advancing women's health and surgical care by providing a diverse range of medical devices, instruments, and services for fertility, obstetrics, and gynecology. The company is dedicated to elevating standards of care by addressing the needs of healthcare providers and patients through continuous innovation and strategic investment.

Recent filings

Filing Released Lang Actions
Management Reports 2024
Management Reports Classification · 95% confidence The document is a detailed letter from The Cooper Companies, Inc. responding to comments from the SEC staff regarding their previously filed Form 10-K for the fiscal year ended October 31, 2023, and Form 10-Q for the quarter ended April 30, 2024. It includes detailed discussions on accounting policies, revenue recognition, intangible assets, and non-GAAP financial measures. The letter also references specific financial data and reconciliations between GAAP and non-GAAP figures, indicating substantive financial content. The presence of detailed financial statements and management explanations aligns with a Management Discussion and Analysis (MDA) type document rather than a full Annual Report (10-K) or a simple regulatory filing. The document is not a report publication announcement or a certification letter but a comprehensive management response with financial analysis and clarifications. Therefore, the best classification is Management Reports (MDA).
2024-07-08 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing mostly non-readable characters and no discernible structured content, titles, or keywords related to any specific financial filing type. There are no clear indications of report titles, fiscal periods, regulatory bodies, or any typical filing content. The document length is 15,000 characters, which is substantial, but the content does not contain meaningful text to classify as a financial report or announcement. Given the lack of identifiable information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific categories.
2024-06-06 English
Regulatory Filings 2024
Regulatory Filings
2024-06-04 English
SD
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the reporting period January 1 to December 31, 2023. It references an attached Conflict Minerals Report as an exhibit but does not contain the full report itself. The document length is 2269 characters, which is relatively short and primarily serves as a disclosure filing rather than a full financial or management report. Form SD filings are specialized regulatory disclosures and do not fit into categories like Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). Given the nature of the filing and its content, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and specialized disclosures that do not fit other categories.
2024-05-31 English
10-Q
Interim / Quarterly Report Q2 2024
2024-05-31 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key section is ITEM 2.02, which states that the company issued a press release reporting results for its fiscal second quarter ended April 30, 2024. The document includes a press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The length of the document is 3371 characters, which is relatively short and consistent with a brief announcement rather than a full interim or quarterly report. The document is primarily an announcement of earnings results, not the earnings release itself or a detailed interim report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing the earnings release but does not contain the full financial data or detailed analysis required for an Interim/Quarterly Report (IR) or Earnings Release (ER).
2024-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.